Cite
HARVARD Citation
Werth, V. et al. (2019). A double‐blind, randomized, placebo‐controlled, phase II trial of baricitinib for systemic lupus erythematosus: how to optimize lupus trials to examine effects on cutaneous lupus erythematosus. British journal of dermatology. pp. 964-965. [Online].